美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

亞盛醫藥

24.52

+0.33001.36%

成交量：1,637.00

成交額：3.97萬

市值：22.88億

市盈率：-12.39

高：24.53

開：23.66

低：23.66

收：24.19

52周最高：48.45

52周最低：17.09

股本：9,333.04萬

流通股本：7,158.28萬

量比：0.47

換手率：0.00%

股息：- -

股息率：- -

每股收益(TTM):-1.9795

每股收益(LYR):-0.7356

淨資產收益率：-159.65%

總資產收益率：-22.77%

市淨率：23.78

市盈率(LYR):-33.34

資料載入中...

總覽公司新聞資訊公告

港股亞盛醫藥-B升逾3%

每日经济新闻

港股異動 | 亞盛醫藥-B(06855)升逾3% 首次揭示奧雷巴替尼通過調控脂質代謝發揮抗腫瘤作用全新機制

亞盛醫藥耐立克®胃腸道間質瘤領域研究進展在國際權威期刊《Signal Transduction and Targeted Therapy》發表

向新而行 | 生物科技新動能驅動產業變革與未來佈局

亞盛醫藥盤中異動早盤急速下跌7.00%

亞盛醫藥：Piper Sandler發布覆蓋評級，給予超配評級；目標價48美元

【2025 ASH】亞盛醫藥耐立克®多項研究入選，POLARIS-1研究數據首次發布

亞盛醫藥-B(06855)耐立克®、利生妥®、APG-5918的多項臨牀進展將在2025年美國血液學會年會(ASH)展示，其中一項獲口頭報告

全球重磅會議ESMO進入倒計時，高彈性港股通創新藥ETF（520880）衝高2%！三生製藥、亞盛醫藥-B強勢領銜

聯儲局10月降息概率高達92%，港股醫藥高位回落

每日经济新闻

每日沽空追蹤 | 亞盛醫藥-B 09月10日沽空量成交12.35萬股，沽空比例為5.15%

亞盛醫藥上漲2.12%，報41.357美元/股，總市值38.53億美元

亞盛醫藥-B09月01日主力淨流入1697.0萬元散户資金拋售

異動解讀 | 亞盛醫藥盤中大跌5.25%，生物醫藥板塊整體承壓

港股生物醫藥股震盪回調，歐康維視生物跌超15%，百奧賽圖、中國抗體跌超8.5%，亞盛醫藥跌超6%。

中金：維持亞盛醫藥-B(06855)跑贏行業評級升目標價至105港元

亞盛醫藥-B：耐立克放量迅速利生妥再加碼差異化佈局

每日沽空追蹤 | 亞盛醫藥-B 08月22日沽空量成交17萬股，沽空比例為5.56%

亞盛醫藥-B08月22日獲主力加倉1782.2萬元

亞盛醫藥耐立克銷售收入按年激增93%，醫保覆蓋成關鍵驅動力

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/AAPG/news?page=2"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AAPG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","market":"US","secType":"STK","nameCN":"亞盛醫藥","latestPrice":24.52,"timestamp":1770411600000,"preClose":24.19,"halted":0,"volume":1637,"delay":0,"changeRate":0.013642000826787858,"floatShares":71582800,"shares":93330405,"eps":-1.979486,"marketStatus":"盤前交易","change":0.33,"latestTime":"02-09 04:37:44 EST","open":23.6625,"high":24.53,"low":23.6625,"amount":39733.4608,"amplitude":0.035862,"askPrice":24.8,"askSize":2400,"bidPrice":9.97,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.979486,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770647400000},"marketStatusCode":1,"adr":0,"adrRate":4,"listingDate":1737694800000,"exchange":"NASDAQ","adjPreClose":24.79,"postHourTrading":{"tag":"盘后","latestPrice":24.52,"preClose":24.52,"latestTime":"16:10 EST","volume":110,"amount":2726.9,"timestamp":1770412204675,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4724386928905639},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","floatShares":71582800,"roa":"-22.77%","roe":"-159.65%","lyrEps":-0.735552,"volumeRatio":0.4724386928905639,"shares":93330405,"dividePrice":0,"high":24.53,"amplitude":0.035862,"preClose":24.19,"low":23.6625,"week52Low":17.09,"pbRate":"23.78","psRate":"40.55","week52High":48.45,"institutionHeld":0,"latestPrice":24.52,"committee":-0.92,"eps":-1.979486,"divideRate":0,"volume":1637,"delay":0,"ttmEps":-1.979486,"open":23.6625,"prevYearClose":26.24,"prevWeekClose":24.52,"prevMonthClose":24.18,"prevQuarterClose":26.24,"fiveDayClose":24.18,"twentyDayClose":27.89,"sixtyDayClose":32.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AAPG\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-20","symbol":"AAPG","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"date":"2025-03-27","symbol":"AAPG","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"盤前","dateTimestamp":1743048000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AAPG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AAPG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1764910800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AAPG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AAPG","date":"2026-02-06","current":-12.387054,"percent":0.992248,"low":-76.454813,"twenty":-42.7913,"median":-29.979764,"eighty":-18.329609,"high":-12.826422,"avg":-32.599658,"sd":16.312833,"marketCap":2208187061.91},"quantilePoints":[{"date":"2025-01-31","current":-29.751262,"twenty":-29.75286,"median":-29.751983,"eighty":-29.751262,"marketCap":1478269659.08},{"date":"2025-02-07","current":-32.664532,"twenty":-32.365221,"median":-31.242401,"eighty":-29.752127,"marketCap":1614694688.16},{"date":"2025-02-14","current":-31.1828,"twenty":-32.258438,"median":-31.212601,"eighty":-29.752938,"marketCap":1540476496.81},{"date":"2025-02-21","current":-36.382297,"twenty":-32.721933,"median":-31.802125,"eighty":-29.819279,"marketCap":1806628873.73},{"date":"2025-02-28","current":-33.43308,"twenty":-34.468465,"median":-32.375664,"eighty":-30.230932,"marketCap":1654638501.56},{"date":"2025-03-07","current":-34.452224,"twenty":-34.328072,"median":-32.712367,"eighty":-30.892818,"marketCap":1712841480.27},{"date":"2025-03-14","current":-33.065652,"twenty":-34.096417,"median":-32.760201,"eighty":-31.20664,"marketCap":1644428002.08},{"date":"2025-03-21","current":-32.72391,"twenty":-34.124503,"median":-32.947597,"eighty":-31.448698,"marketCap":1626713850.02},{"date":"2025-03-28","current":-33.955809,"twenty":-34.124503,"median":-33.010704,"eighty":-31.793328,"marketCap":1894714451.86},{"date":"2025-04-04","current":-35.921968,"twenty":-34.855052,"median":-33.21342,"eighty":-31.979778,"marketCap":2000185586.04},{"date":"2025-04-11","current":-29.511221,"twenty":-34.370118,"median":-33.010704,"eighty":-30.892818,"marketCap":1635879540.94},{"date":"2025-04-17","current":-29.520055,"twenty":-34.225935,"median":-32.760201,"eighty":-30.07059,"marketCap":1639709582.7},{"date":"2025-04-25","current":-41.553435,"twenty":-35.045268,"median":-32.920123,"eighty":-30.119556,"marketCap":2311372741.24},{"date":"2025-05-02","current":-38.492689,"twenty":-35.554336,"median":-33.187028,"eighty":-30.682879,"marketCap":2146245101.28},{"date":"2025-05-09","current":-37.35919,"twenty":-36.170996,"median":-33.361942,"eighty":-30.776099,"marketCap":2093177176.92},{"date":"2025-05-16","current":-35.007117,"twenty":-35.955639,"median":-33.43308,"eighty":-31.102567,"marketCap":1969122395.28},{"date":"2025-05-23","current":-39.338512,"twenty":-36.352488,"median":-33.608398,"eighty":-31.19472,"marketCap":2213435510.22},{"date":"2025-05-30","current":-38.856398,"twenty":-37.35919,"median":-33.992043,"eighty":-31.242401,"marketCap":2192363417.29},{"date":"2025-06-06","current":-42.814884,"twenty":-37.865895,"median":-34.141844,"eighty":-31.758144,"marketCap":2419987007.19},{"date":"2025-06-13","current":-48.171029,"twenty":-38.492689,"median":-34.477812,"eighty":-31.846105,"marketCap":2722575737.57},{"date":"2025-06-20","current":-55.929302,"twenty":-38.862859,"median":-34.635358,"eighty":-32.113451,"marketCap":3154688383.5},{"date":"2025-06-27","current":-59.787237,"twenty":-39.399619,"median":-35.123604,"eighty":-32.336589,"marketCap":3381751544.24},{"date":"2025-07-03","current":-64.068526,"twenty":-41.436089,"median":-35.258863,"eighty":-32.429915,"marketCap":3624015684.35},{"date":"2025-07-11","current":-59.084566,"twenty":-43.897892,"median":-35.501693,"eighty":-32.48435,"marketCap":3338745741.38},{"date":"2025-07-18","current":-61.880278,"twenty":-48.308604,"median":-35.791073,"eighty":-32.545465,"marketCap":3494679880.36},{"date":"2025-07-25","current":-58.315576,"twenty":-54.849764,"median":-35.921968,"eighty":-32.616809,"marketCap":3304687864.64},{"date":"2025-08-01","current":-60.559654,"twenty":-57.422661,"median":-36.233253,"eighty":-32.655768,"marketCap":3410643633.03},{"date":"2025-08-08","current":-69.260076,"twenty":-59.023969,"median":-36.597865,"eighty":-32.679287,"marketCap":3910472388.03},{"date":"2025-08-15","current":-72.346957,"twenty":-59.602544,"median":-37.391167,"eighty":-32.709995,"marketCap":4086922647.44},{"date":"2025-08-22","current":-26.724459,"twenty":-60.097702,"median":-37.493155,"eighty":-32.679287,"marketCap":4314209810.62},{"date":"2025-08-29","current":-24.396919,"twenty":-59.865528,"median":-36.699167,"eighty":-32.48435,"marketCap":3966417985.85},{"date":"2025-09-05","current":-22.946281,"twenty":-59.664109,"median":-36.382297,"eighty":-31.979778,"marketCap":3724203040.4},{"date":"2025-09-12","current":-22.941741,"twenty":-59.475774,"median":-35.943012,"eighty":-31.122625,"marketCap":3735810338.07},{"date":"2025-09-19","current":-21.785524,"twenty":-59.316014,"median":-35.857966,"eighty":-29.943039,"marketCap":3550375801.58},{"date":"2025-09-26","current":-21.102028,"twenty":-59.062646,"median":-35.66937,"eighty":-29.751262,"marketCap":3428719452.06},{"date":"2025-10-03","current":-22.266298,"twenty":-59.025902,"median":-35.30284,"eighty":-28.699054,"marketCap":3625414266.5},{"date":"2025-10-10","current":-21.050291,"twenty":-58.738293,"median":-35.189473,"eighty":-26.732175,"marketCap":3423480133.18},{"date":"2025-10-17","current":-19.80269,"twenty":-58.191808,"median":-34.731922,"eighty":-24.468638,"marketCap":3221889328.22},{"date":"2025-10-24","current":-19.801335,"twenty":-57.904825,"median":-34.477812,"eighty":-23.569995,"marketCap":3222890223.42},{"date":"2025-10-31","current":-19.321494,"twenty":-57.532716,"median":-34.141844,"eighty":-22.943557,"marketCap":3150231208.59},{"date":"2025-11-07","current":-18.112503,"twenty":-56.69325,"median":-33.992043,"eighty":-22.558349,"marketCap":2949090425.48},{"date":"2025-11-14","current":-19.583345,"twenty":-55.920234,"median":-33.485756,"eighty":-22.342071,"marketCap":3199584585.23},{"date":"2025-11-21","current":-17.547753,"twenty":-55.765092,"median":-33.408485,"eighty":-22.122489,"marketCap":2860955000.96},{"date":"2025-11-28","current":-18.539078,"twenty":-55.318442,"median":-33.361942,"eighty":-21.796498,"marketCap":3034915066.08},{"date":"2025-12-05","current":-18.33416,"twenty":-53.27811,"median":-33.187028,"eighty":-21.590149,"marketCap":3005486168.49},{"date":"2025-12-12","current":-17.062052,"twenty":-48.796704,"median":-32.920123,"eighty":-21.073758,"marketCap":2802301628.68},{"date":"2025-12-19","current":-16.188794,"twenty":-48.517949,"median":-32.72391,"eighty":-20.125041,"marketCap":2665447409.6},{"date":"2025-12-26","current":-15.347054,"twenty":-48.514967,"median":-32.664532,"eighty":-19.801335,"marketCap":2537308174.25},{"date":"2026-01-02","current":-14.520508,"twenty":-48.239817,"median":-32.57809,"eighty":-19.656119,"marketCap":2406972911.39},{"date":"2026-01-09","current":-15.636938,"twenty":-46.480698,"median":-32.420873,"eighty":-19.300607,"marketCap":2595562368.02},{"date":"2026-01-16","current":-14.792082,"twenty":-45.997596,"median":-31.846105,"eighty":-19.073232,"marketCap":2461528990.12},{"date":"2026-01-23","current":-14.451393,"twenty":-45.706429,"median":-31.242401,"eighty":-18.892753,"marketCap":2402559084.95},{"date":"2026-01-30","current":-13.594278,"twenty":-43.897892,"median":-30.891003,"eighty":-18.486342,"marketCap":2268064814.82},{"date":"2026-02-06","current":-13.215954,"twenty":-42.7913,"median":-29.979764,"eighty":-18.329609,"marketCap":2208187061.91}],"updateTime":1770629864308},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AAPG\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2586284951","title":"港股亞盛醫藥-B升逾3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586284951","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586284951?lang=zh_tw&edition=fundamental","pubTime":"2025-11-26 11:03","pubTimestamp":1764126180,"startTime":"0","endTime":"0","summary":"每经AI快讯，亚盛医药-B(06855.HK)涨超3%，截至发稿，涨3.04%，报64.35港元，成交额4604.84万港元。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-11-26/doc-infysxme3338276.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-11-26/doc-infysxme3338276.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06855","BK1161","BK4139","AAPG","BK1574"],"gpt_icon":0},{"id":"2586281468","title":"港股異動 | 亞盛醫藥-B(06855)升逾3% 首次揭示奧雷巴替尼通過調控脂質代謝發揮抗腫瘤作用全新機制","url":"https://stock-news.laohu8.com/highlight/detail?id=2586281468","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586281468?lang=zh_tw&edition=fundamental","pubTime":"2025-11-26 10:47","pubTimestamp":1764125279,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，亚盛医药-B涨超3%，截至发稿，涨3.04%，报64.35港元，成交额4604.84万港元。研究结果表明奥雷巴替尼在琥珀酸脱氢酶缺陷型GIST中具有良好的疗效与安全性，并首次揭示奥雷巴替尼通过调控脂质代谢发挥抗肿瘤作用的全新机制。据悉，这是迄今为止针对该罕见GIST亚型规模最大的前瞻性临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373726.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4139","BK1161","AAPG","06855"],"gpt_icon":0},{"id":"2586044224","title":"亞盛醫藥耐立克®胃腸道間質瘤領域研究進展在國際權威期刊《Signal Transduction and Targeted Therapy》發表","url":"https://stock-news.laohu8.com/highlight/detail?id=2586044224","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586044224?lang=zh_tw&edition=fundamental","pubTime":"2025-11-25 10:34","pubTimestamp":1764038040,"startTime":"0","endTime":"0","summary":"《信号转导与靶向治疗》是国际知名权威期刊，隶属于《自然》出版集团。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4832671_ZH32671_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1161","BK4139","BK1574","AAPG","06855"],"gpt_icon":0},{"id":"2585176023","title":"向新而行 | 生物科技新動能驅動產業變革與未來佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2585176023","media":"南方基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585176023?lang=zh_tw&edition=fundamental","pubTime":"2025-11-22 13:11","pubTimestamp":1763788269,"startTime":"0","endTime":"0","summary":"实验室的光点亮创新的方向政策的风吹起医药产业的帆扬当新质生产力渗入制药方程中国生物科技，正书写新的篇章把握医药行业“向新而行，以质致远”的发展图景，需要洞察其深层动力：揭示中国生物科技跻身全球第一梯队的路径与产业链韧性成因，解读生物科技企业发展的核心驱动逻辑，并前瞻中药、创新器械等关键赛道的未来机遇。03政策、体系、人才三重驱动，支持生物科技企业中国生物科技企业崛起，依托三大关键支撑。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122131246a4b2f4ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251122131246a4b2f4ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","06978","BK1161","BK1574","06855"],"gpt_icon":0},{"id":"2584327965","title":"亞盛醫藥盤中異動 早盤急速下跌7.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584327965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584327965?lang=zh_tw&edition=fundamental","pubTime":"2025-11-19 00:00","pubTimestamp":1763481637,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日00时00分，亚盛医药股票出现异动，股价大幅跳水7.00%。截至发稿，该股报30.42美元/股，成交量594股，换手率0.00%，振幅0.52%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。亚盛医药股票所在的生物技术行业中，整体跌幅为0.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119000037a70249a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119000037a70249a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","06855","AAPG"],"gpt_icon":0},{"id":"1163861320","title":"亞盛醫藥：Piper Sandler發布覆蓋評級，給予超配評級；目標價48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1163861320","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163861320?lang=zh_tw&edition=fundamental","pubTime":"2025-11-05 17:03","pubTimestamp":1762333390,"startTime":"0","endTime":"0","summary":"亚盛医药：Piper Sandler发布覆盖评级，给予超配评级；目标价48美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4139","06855","BK1574","AAPG"],"gpt_icon":0},{"id":"2580279202","title":"【2025 ASH】亞盛醫藥耐立克®多項研究入選，POLARIS-1研究數據首次發布","url":"https://stock-news.laohu8.com/highlight/detail?id=2580279202","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580279202?lang=zh_tw&edition=fundamental","pubTime":"2025-11-04 09:21","pubTimestamp":1762219260,"startTime":"0","endTime":"0","summary":"公司将在此次ASH年会上，首次发布耐立克联合低强度化疗治疗初治费城染色体阳性（Ph+）急性淋巴细胞白血病患者的全球III期研究最新数据。一年一度的ASH年会是全球血液学领域规模最大的国际学术盛会之一，全面涵盖了血液疾病的病因研究和治疗研究。此外，今年公司3个重点品种有多项进展入选ASH年会展示及报告，充分显现了公司的全球创新和开发实力。未来，亚盛医药将进一步加速推进临床开发，早日为患者带来更多治疗选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4814666_ZH14666_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1161","AAPG","BK1574","06855","BK4139","LU2463526074.USD","ASH","BK4109"],"gpt_icon":0},{"id":"2580220496","title":"亞盛醫藥-B(06855)耐立克®、利生妥®、APG-5918的多項臨牀進展將在2025年美國血液學會年會(ASH)展示，其中一項獲口頭報告","url":"https://stock-news.laohu8.com/highlight/detail?id=2580220496","media":"智通财经","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580220496?lang=zh_tw&edition=fundamental","pubTime":"2025-11-04 08:21","pubTimestamp":1762215703,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚盛医药-B 发布公告，公司3个品种有多项临床和临床前进展入选第67届美国血液学会年会展示及报告，其中一项获口头报告。此外，公司原创1类新药利沙托克拉共 有 2项临床进展获选第67届ASH年会，其中一项获口头报告。这是该品种的临床进展连续第4年入选 ASH年会。第67届ASH年会将于当地时间2025年12月6 日至12月9日间在美国佛罗里达州奥兰多市以线下结合线上的形式举行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1364794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1161","APG","LU2125909759.SGD","LU2463526074.USD","BK4129","LU1923622291.USD","BK4109","06855","BK4139","LU2125909916.SGD","ASH","AAPG"],"gpt_icon":0},{"id":"2575720858","title":"全球重磅會議ESMO進入倒計時，高彈性港股通創新藥ETF（520880）衝高2%！三生製藥、亞盛醫藥-B強勢領銜","url":"https://stock-news.laohu8.com/highlight/detail?id=2575720858","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575720858?lang=zh_tw&edition=fundamental","pubTime":"2025-10-15 14:30","pubTimestamp":1760509800,"startTime":"0","endTime":"0","summary":"10月15日午后，港股通创新药板块持续拉升，亚盛医药-B领涨近6%，科伦博泰生物-B、同源康医药-B、三生制药等多股反弹逾4%。　　港股通创新药ETF100%布局创新药研发类公司，午后震荡上扬，场内涨幅一度冲上2%，成交超3.4亿元。此前3日港股通创新药ETF已获超1.29亿元资金逢跌净申购。　　产业方面，日前诺诚健华达成1亿美金首付款、总价超过20亿美金BD交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-10-15/doc-inftxywn3617176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4139","BK1583","BK1574","BK1161","01530","520880","06855","AAPG","BK1593"],"gpt_icon":0},{"id":"2569099557","title":"聯儲局10月降息概率高達92%，港股醫藥高位回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2569099557","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569099557?lang=zh_tw&edition=fundamental","pubTime":"2025-09-24 10:11","pubTimestamp":1758679917,"startTime":"0","endTime":"0","summary":"美联储于9月18日如期宣布降息25bp，为港股市场提供了较为宽松的流动性环境。但当前距离10月29日议息尚有35天，美联储相关官员的发言在短期内引起较大扰动。据CME FedWatch Tool数据，美联储10月降息25bp的概率为91.9%；12月降息25bp的概率为21.7%，降息50bp的概率为77%。从二级市场来看，聚焦港股市场创新药+CXO的恒生医药ETF连续调整，自阶段高点回落近6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092410141595415b18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"ea3b3b54e2aa42d2aadd6617f904fcb8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025092410141595415b18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588",".SPX","OEX","SPY","MESmain","BK4139","SSO","09688","BK4504","ESmain","BK4534","BK4585","BK4550","09606","AAPG","SPXU","UPRO","BK4559","BK4581","IVV","SH","OEF","SDS"],"gpt_icon":0},{"id":"2566698828","title":"每日沽空追蹤 | 亞盛醫藥-B 09月10日沽空量成交12.35萬股，沽空比例為5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2566698828","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566698828?lang=zh_tw&edition=fundamental","pubTime":"2025-09-10 16:30","pubTimestamp":1757493041,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间09月10日，跌1.68%，卖空量成交12.35万股，较上一交易日减少57.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091016350697851d0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091016350697851d0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2565870726","title":"亞盛醫藥上漲2.12%，報41.357美元/股，總市值38.53億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565870726","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565870726?lang=zh_tw&edition=fundamental","pubTime":"2025-09-08 22:16","pubTimestamp":1757340962,"startTime":"0","endTime":"0","summary":"据交易所数据显示，9月8日，亚盛医药盘中上涨2.12%，截至22:16，报41.357美元/股，成交48.07万美元，总市值38.53亿美元。财务数据显示，截至2025年06月30日，亚盛医药收入总额2.34亿人民币，同比减少71.63%；归母净利润-5.91亿人民币，同比减少462.43%。目前公司正在中国、美国、澳大利亚及欧洲开展40多项临床试验。截至目前,公司共有4个在研新药获得16项FDA和1项欧盟孤儿药资格认定,2项FDA快速通道资格以及2项FDA儿童罕见病资格认证。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/08221653004732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4139","AAPG"],"gpt_icon":0},{"id":"2564781953","title":"亞盛醫藥-B09月01日主力淨流入1697.0萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2564781953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564781953?lang=zh_tw&edition=fundamental","pubTime":"2025-09-01 16:15","pubTimestamp":1756714535,"startTime":"0","endTime":"0","summary":"09月01日, 亚盛医药-B股价涨0.12%，报收83.25元，成交金额2.4亿元，换手率0.78%，振幅2.77%，量比0.59。亚盛医药-B今日主力资金净流入1697.0万元，上一交易日主力净流出815.6万元。该股近5个交易日下跌3.42%，主力资金累计净流出1557.3万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入5220.1万元，其中净流入天数为8日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901170942a7090fba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250901170942a7090fba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"1136407164","title":"異動解讀 | 亞盛醫藥盤中大跌5.25%，生物醫藥板塊整體承壓","url":"https://stock-news.laohu8.com/highlight/detail?id=1136407164","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136407164?lang=zh_tw&edition=fundamental","pubTime":"2025-08-25 21:32","pubTimestamp":1756128779,"startTime":"0","endTime":"0","summary":"8月25日周一盘中，亚盛医药股价出现大幅下跌，跌幅达5.25%，引发市场关注。此次下跌主要受到生物医药板块整体走弱的影响。其中，欧康维视生物跌幅超过15%，百奥赛图和中国抗体跌幅均超过8.5%，亚盛医药跌幅超过6%。这一行业性下跌趋势可能是导致亚盛医药股价下跌的主要原因。值得注意的是，尽管股价下跌，但亚盛医药近期获得了积极的分析师评价。中金公司维持亚盛医药\"跑赢行业\"评级，并将目标价上调19.3%至105港元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["AAPG"],"gpt_icon":0},{"id":"2562291249","title":"港股生物醫藥股震盪回調，歐康維視生物跌超15%，百奧賽圖、中國抗體跌超8.5%，亞盛醫藥跌超6%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2562291249","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562291249?lang=zh_tw&edition=fundamental","pubTime":"2025-08-25 10:51","pubTimestamp":1756090312,"startTime":"0","endTime":"0","summary":"港股生物医药股震荡回调，欧康维视生物跌超15%，百奥赛图、中国抗体跌超8.5%，亚盛医药跌超6%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/25105152660744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["07226","BK4139","161726","HSTECH","BK1161","399441","03681","YANG","AAPG","HSCEI","BK4614","BK1574"],"gpt_icon":0},{"id":"2562291614","title":"中金：維持亞盛醫藥-B(06855)跑贏行業評級 升目標價至105港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562291614","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562291614?lang=zh_tw&edition=fundamental","pubTime":"2025-08-25 10:39","pubTimestamp":1756089589,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中金发布研报称，维持亚盛医药-B2025年/2026年归母净利润预测不变，维持跑赢行业评级，考虑到GLORA-4进展，新适应症空间可见度提升，根据DCF模型，上调目标价19.3%至105港币，离当前股价有15.8%的上行空间。公司1H25收入2.34亿元，主要由于去年同期产生授权收入，1H25业绩符合该行预期。该行认为MDS患者人群广泛，一线治疗存在较大未满足需求，公司利生妥这一布局有望加码其差异化优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["AAPG","06855"],"gpt_icon":0},{"id":"2561250107","title":"亞盛醫藥-B：耐立克放量迅速 利生妥再加碼差異化佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2561250107","media":"中金公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561250107?lang=zh_tw&edition=fundamental","pubTime":"2025-08-24 00:00","pubTimestamp":1755964800,"startTime":"0","endTime":"0","summary":"发展趋势耐立克新适应进入医保带来上半年商业化收入高速增长，下半年利沙妥克拉获批上市有望贡献新增长点。根据公司公告，截至公告日，利生妥是国际唯一正推进中高危MDS 注册III 期临床的Bcl-2 抑制剂，有望打破该领域长期空白。此前2025ASCO 上发表的数据表明，利生妥联合阿扎胞苷治疗初治MDS 的ORR 达到75%，且安全性良好。我们认为MDS 患者人群广泛，一线治疗存在较大未满足需求，公司利生妥这一布局有望加码其差异化优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250824143619a6f81ba9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250824143619a6f81ba9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2561147611","title":"每日沽空追蹤 | 亞盛醫藥-B 08月22日沽空量成交17萬股，沽空比例為5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561147611","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561147611?lang=zh_tw&edition=fundamental","pubTime":"2025-08-22 16:30","pubTimestamp":1755851437,"startTime":"0","endTime":"0","summary":"亚盛医药-B北京时间08月22日，涨0.5%，卖空量成交17万股%，较上一交易日减少39.2%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822174123a4983e1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822174123a4983e1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2561476199","title":"亞盛醫藥-B08月22日獲主力加倉1782.2萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2561476199","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561476199?lang=zh_tw&edition=fundamental","pubTime":"2025-08-22 16:15","pubTimestamp":1755850533,"startTime":"0","endTime":"0","summary":"08月22日, 亚盛医药-B股价涨0.50%，报收90.65元，成交金额2.8亿元，换手率0.82%，振幅3.82%，量比0.68。亚盛医药-B今日主力资金净流入1782.2万元，上一交易日主力净流入1179.5万元。该股近5个交易日上涨5.05%，主力资金累计净流出1001.0万元；近20日主力资金累计净流入6971.9万元，其中净流入天数为9日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822170525a6f52b47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250822170525a6f52b47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AAPG","BK4139"],"gpt_icon":0},{"id":"2561761424","title":"亞盛醫藥耐立克銷售收入按年激增93%，醫保覆蓋成關鍵驅動力","url":"https://stock-news.laohu8.com/highlight/detail?id=2561761424","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561761424?lang=zh_tw&edition=fundamental","pubTime":"2025-08-22 12:16","pubTimestamp":1755836163,"startTime":"0","endTime":"0","summary":"亚盛医药近日公布2025年上半年业绩，其核心产品耐立克销售收入同比增长93%，达到人民币2.17亿元。业绩显著增长主要得益于该药物被纳入国家医保目录后覆盖范围的持续扩大，市场可及性进一步提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082212192194f3cd4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082212192194f3cd4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AAPG"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":55,"code":"91000000","status":"200"}]}}